However, one possible explanation for the progressive populations reviewed typically having lower NfL than the RRMS populations may be explained by the inclusion of progressive participants that had relatively inactive MS overall: the proportion of active PMS participants was typically less than one-third and often less than one-tenth. The gene discussed is NEFL; the disease is myeloid sarcoma.